Squarepoint’s Gritstone bio GRTS Stock Holding History
Bought
Maintained
Sold
Other funds holding GRTS
SL
Squarepoint's GRTS Position: Q3 2024 in Review
Squarepoint sold out of Gritstone bio (GRTS) in Q3 2024, closing a stake of 64,929 shares — an estimated $40.1K sold.
Squarepoint first reported a position in GRTS in Q4 2018 and held it in 14 quarters. The position peaked at $858K in Q4 2021. 56 funds tracked by Wall St. Rank hold GRTS as of Q3 2024.
- Squarepoint reported no remaining Gritstone bio position as of Q3 2024 after selling out during the quarter.
- Squarepoint sold 64,929 Gritstone bio shares in Q3 2024, an estimated $40.1K.
- Squarepoint first reported a position in Gritstone bio in Q4 2018 and held it in 14 quarters.
- Squarepoint's Gritstone bio position peaked at $858K in Q4 2021.
- 56 funds tracked by Wall St. Rank held Gritstone bio as of Q3 2024.
Based on Squarepoint's 13F filing for Q3 2024, filed 14 Nov 2024.